Volume 11, Number 12—December 2005
Influenza Virus Infection in Racing Greyhounds
To the Editor: Influenza is globally the most economically important respiratory disease in humans, pigs, horses, and fowl (1). Influenza virus is known for its continuous genetic and antigenic changes, which impedes effective influenza control (1,2). More importantly, emergence of a new subtype by genetic reassortment or interspecies transmission is of great concern for preventing influenza epidemics and pandemics (1). Recently, influenza outbreaks have occurred in species (feline and canine) that historically do not carry influenza virus (3,4), which alerted both regulatory and scientific communities to expansion of the host range of influenza virus. We report an outbreak of respiratory disease by influenza virus infection in Iowa racing greyhounds after influenza outbreaks in Florida in 2004.
In mid-April, an influx of racing greyhounds into Iowa greyhound tracks resulted in outbreaks of respiratory disease within the track compounds. The disease was characterized by rapid onset of fever and cough, rapid respiration, and hemorrhagic nasal discharge. The illness rate was almost 100% in both racetrack compounds, although the death rate was <5%. Most affected dogs recovered, yet many died of hemorrhagic pneumonia. Therapeutic administration of broad-spectrum antimicrobial drugs reduced the severity of the disease but could not control it.
Tissue samples from 4 animals that died of severe pneumonia were submitted to the Iowa State University Veterinary Diagnostic Laboratory. The animals represented 2 different racing tracks located in eastern and western Iowa. On gross examination, lungs exhibited extensive red to red-black discoloration with moderate to marked palpable firmness. Mild fibrinous pleuritis was also noted. Microscopically, lung sections were characterized by severe hemorrhagic interstitial to bronchointerstitial pneumonia. Patchy interstitial change with alveolar septal thickening, coagula of debris in alveoli, and associated atelectasis were evident. Focally extensive pyogranulomatous bronchointerstitial pneumonia with dilatation of airways by degenerate cells and debris was observed. Scattered vasculitis and vascular thrombi were apparent.
Microbiologic testing for conventional viral and bacterial agents did not show any important pathogens except Streptococcus equi subsp. zooepidemicus from lung tissues of all animals examined. Two of the 4 lung samples were positive for influenza A virus by a real-time reverse transcription–polymerase chain reaction (RT-PCR) (5). Viral pneumonic lesions of both lungs were positive for immunohistochemistry (IHC) with monoclonal antibody specific for the nucleoprotein of influenza A virus (6) and with antigen-capturing enzyme-linked immunosorbent assay (Directigen Flu A, Becton-Dickinson, Sparks, MD, USA). Bronchioalveolar lavage samples from the 2 positive lungs were also positive by RT-PCR for influenza A virus.
Virus isolation was attempted; the influenza virus in canine lungs was unexpected since no influenza virus infection in dogs had been reported, except a recent communication at a meeting of veterinary diagnosticians (4). A virus that was able to agglutinate rooster erythrocytes was isolated in Madin-Darby canine kidney cells from lung and bronchioalveolar lavage fluid of 1 of the 2 animals in which influenza virus was detected by IHC and RT-PCR. Isolates were determined by RT-PCR to be influenza A virus of H3 subtype. The US Department of Agriculture National Veterinary Services Laboratory (Ames, IA) subtyped the virus isolates (A/Canine/Iowa/13628/2005) as H3N8 by using hemagglutination-inhibition assay and neuraminidase-inhibition assay.
Sequencing hemagglutinin (HA) and neuraminidase (NA) genes of both isolates showed 100% and 99.8% identity, respectively, between the 2 isolates. Phylogenetically, the HA gene (GenBank accession no. DQ146419) of the isolates was genetically close (96%–98% nucleotide homology) to the HA gene of recent H3N8 equine influenza viruses (7). The NA gene (DQ146420) of the isolates also showed 96%–98% homology with the NA gene of recent H3N8 equine influenza viruses. Internal genes remain to be sequenced.
In conclusion, recent outbreaks of hemorrhagic pneumonia and associated deaths in Iowa racing greyhounds were primarily due to infection by an H3N8 influenza virus genetically and antigenically similar to equine influenza viruses. This conclusion can be supported by a previous report of fatal hemorrhagic pneumonia by H3N8 virus infection in racing greyhounds in Florida (4). The fact that greyhounds in 2 different racetracks, which are in geographically remote sites in Iowa, simultaneously died of the disease without the involvement of sick horses suggests that the influenza virus isolate is likely a canine-adapted strain and able to perpetuate and spread among dogs. While influenza virus infection was likely responsible for the disease outbreaks, the contribution that S. zooepidemicus might have made to the disease and the severity of clinical manifestations remains to be further evaluated since the bacterium has been implicated in respiratory disease and septicemia-associated problems in many different animal species (8,9).
We thank staff in Virology and Bacteriology Sections at the Iowa State University Veterinary Diagnostic Laboratory for their timely and excellent technical assistance in laboratory testing.
- Wright PF, Webster RG. Fields virology. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, et al. (editors). Orthomyxoviruses. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1533–79.
- Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56:152–79.
- Keawcharoen J, Oraveerakul K, Kuiken T, Fouchier RA, Amonsin A, Payungporn S, Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis. 2004;10:2189–91.
- Dubovi EJ, Craford CW, Donis RO, Castleman WL, Stephenson I, Gibbs EPJ. Isolation of equine influenza virus from racing greyhounds with fatal hemorrhagic pneumonia. In: Proceedings of the 47th Annual Meeting of American Association of Veterinary Laboratory Diagnosticians; 2004 October; Greensboro, North Carolina. p. 158.
- Harmon KM, Krauss S, Yoon K-J. Development of a PCR-based differential test for H1N1 and H3N2 swine influenza viruses. In: Proceedings of the 42nd Annual Meeting of American Association of Veterinary Laboratory Diagnosticians; 1999 October; San Diego, California. p. 44.
- Vincent LL, Janke BH, Paul PS, Halbur PG. A monoclonal-antibody-based immunohistochemical method for the detection of swine influenza virus in formalin-fixed, paraffin-embedded tissues. J Vet Diagn Invest. 1997;9:191–5.
- Macken C, Lu H, Goodman J, Boykin L. Options for the control of influenza IV. In: Osterhaus ADME, Cox N, Hampson AW (editors). The value of a database in surveillance and vaccine selection. Amsterdam: Elsevier Science; 2001. p. 103–6.
- Wood JL, Newton JR, Chanter N, Mumford JA. Association between respiratory disease and bacterial and viral infections in British racehorses. J Clin Microbiol. 2005;43:120–6.
- Gillespie JH, Timoney JF, eds. The genera Staphylococcus and Streptococcus. In: Hagan and Bruner's infectious diseases of domestic animals. 7th ed. Ithaca (NY): Comstock/Cornell University Press; 1981. p. 164–80.
Suggested citation for this article: Yoon K-J, Cooper VL, Schwartz KJ, Harmon KM, Kim W-II, Janke BH, et al. Influenza virus infection in racing greyhounds [letter]. Emerg Infect Dis [serial on the Internet]. 2005 Dec [date cited]. http://dx.doi.org/10.3201/eid1112.050810
Please use the form below to submit correspondence to the authors or contact them at the following address:
Kyoung-Jin Yoon, Iowa State University, Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, 1600 South 16th St, Ames, IA 50011, USA; fax: 515-294-6619
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: February 02, 2012
- Page last updated: February 02, 2012
- Page last reviewed: February 02, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)